Related Experiment Video
Updated: Jun 18, 2026
06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
Statistical evaluation of the Local Lymph Node Assay
Ludwig A Hothorn1, Hans-Werner Vohr
1Institute of Biostatistics, Leibniz University Hannover, Germany. hothorn@biostat.uni-hannover.de
Regulatory Toxicology and Pharmacology : RTP
|November 20, 2009
Summary
The Local Lymph Node Assay evaluates immune responses using endpoints like cell proliferation. A positive result indicates a hazard, while safety is concluded if results fall within tolerable limits, demonstrating proof of safety.
Area of Science:
- Immunotoxicology
- Dermatology
- Allergenicity Assessment
Background:
- The Local Lymph Node Assay (LLNA) is a key method for assessing skin sensitization potential.
- Accurate interpretation of LLNA data is crucial for regulatory submissions and risk assessment.
Purpose of the Study:
- To detail the evaluation of measured endpoints in the Local Lymph Node Assay.
- To define criteria for concluding a positive response (hazard identification) and a negative response (proof of safety).
Main Methods:
- Separate evaluation of individual animal endpoints: cell proliferation, cell counts, and lymph node weight.
- Calculation of stimulation index (SI) and ratio-to-control comparisons with confidence limits.
Main Results:
- A positive response is determined by an estimated stimulation index exceeding a specific threshold.
- Proof of hazard is established when the lower confidence limit for ratio-to-control exceeds a relevance threshold.
- Proof of safety is concluded if the upper confidence limit for ratio-to-control falls below a tolerable margin.
Conclusions:
- The LLNA provides a robust framework for assessing skin sensitization.
- Clear criteria for hazard and safety conclusions enhance the reliability of the assay.
- Endpoint-specific thresholds and confidence limit analyses are vital for accurate interpretation.
